FineTest
SKU:FNab01307
anti- Cathepsin F antibody
anti- Cathepsin F antibody
Couldn't load pickup availability
Our Anti-Cathepsin F Antibody (100µg) is a critical research tool for scientists investigating Cathepsin F and its essential roles in lysosomal protein degradation, antigen processing, and immune regulation. Cathepsin F, a member of the cysteine protease family, participates in the turnover of cellular proteins and has implications in immune responses. This antibody, meticulously designed to specifically target Cathepsin F, ensures precise and reliable results in your experiments.
With 100µg of this high-quality antibody per vial, you'll have an ample supply for multiple experiments, reducing the need for frequent reordering. Whether you're conducting enzyme activity assays to study Cathepsin F function in antigen processing or exploring its potential as a therapeutic target in autoimmune diseases, this antibody consistently delivers outstanding performance.
Researchers can trust the exceptional specificity and sensitivity of this antibody, produced using advanced techniques and premium-grade materials. Its reliability makes it an indispensable asset for projects aimed at deciphering the complex roles of Cathepsin F in immune regulation and diseases.
Empower your research on lysosomal biology and immune responses with confidence using our Anti-Cathepsin F Antibody. By utilizing this antibody, you contribute to the broader understanding of protein degradation mechanisms and their implications in health and disease.
Product Name
Cathepsin F antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
IMMUNOGEN INFORMATION
Immunogen
cathepsin F
Observed MW
54-60 kDa
APPLICATION
Tested Application
ELISA, IHC, WB
Recommended Dilution
WB: 1:500-1:2000; IHC: 1:20-1:200
UNIPROT INFORMATION
UniProt ID
IMAGES


Share
